Scarica l'app Stockscreener
124.41
1.98%
2.41
Dopo l'orario di chiusura:
124.12
-0.29
-0.23%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AXSM Giù?
Forum
Previsione
Precedente Chiudi:
$122.00
Aprire:
$121.81
Volume 24 ore:
470.74K
Relative Volume:
0.74
Capitalizzazione di mercato:
$6.21B
Reddito:
$338.46M
Utile/perdita netta:
$-310.96M
Rapporto P/E:
-19.05
EPS:
-6.53
Flusso di cassa netto:
$-132.82M
1 W Prestazione:
+2.18%
1M Prestazione:
+16.77%
6M Prestazione:
-0.92%
1 anno Prestazione:
+30.19%
Intervallo 1D:
$121.75
$124.52
Intervallo di 1 settimana:
$119.93
$124.61
Portata 52W:
$75.56
$139.13
Axsome Therapeutics Inc Stock (AXSM) Company Profile
Nome
Axsome Therapeutics Inc
Settore
Industria
Telefono
(212) 332-3241
Indirizzo
ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK
Confronta AXSM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AXSM
Axsome Therapeutics Inc
|
124.41 | 6.16B | 338.46M | -310.96M | -132.82M | -6.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Axsome Therapeutics Inc Stock (AXSM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-03 | Ripresa | Morgan Stanley | Overweight |
| 2025-06-03 | Iniziato | Oppenheimer | Outperform |
| 2025-04-07 | Iniziato | Jefferies | Buy |
| 2025-02-11 | Iniziato | Deutsche Bank | Buy |
| 2024-12-31 | Reiterato | Mizuho | Outperform |
| 2024-09-03 | Iniziato | Wells Fargo | Overweight |
| 2024-08-06 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-07-22 | Iniziato | Needham | Buy |
| 2024-04-29 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-03-19 | Iniziato | Robert W. Baird | Outperform |
| 2024-02-06 | Iniziato | UBS | Buy |
| 2024-01-25 | Iniziato | RBC Capital Mkts | Outperform |
| 2023-12-13 | Iniziato | Citigroup | Buy |
| 2023-08-08 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2023-01-05 | Iniziato | Piper Sandler | Neutral |
| 2022-11-01 | Iniziato | Loop Capital | Buy |
| 2022-09-07 | Ripresa | Mizuho | Buy |
| 2021-08-10 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-10 | Iniziato | Berenberg | Buy |
| 2021-01-08 | Iniziato | Jefferies | Buy |
| 2020-12-16 | Iniziato | Mizuho | Buy |
| 2020-09-29 | Iniziato | BofA Securities | Underperform |
| 2020-09-10 | Iniziato | Morgan Stanley | Overweight |
| 2020-04-28 | Reiterato | H.C. Wainwright | Buy |
| 2020-04-14 | Iniziato | Cowen | Outperform |
| 2019-12-30 | Reiterato | H.C. Wainwright | Buy |
| 2019-12-17 | Reiterato | H.C. Wainwright | Buy |
| 2019-12-16 | Reiterato | Guggenheim | Buy |
| 2019-10-16 | Iniziato | Guggenheim | Buy |
| 2019-09-18 | Iniziato | William Blair | Outperform |
| 2019-05-28 | Iniziato | SunTrust | Buy |
| 2019-05-23 | Reiterato | H.C. Wainwright | Buy |
| 2019-04-08 | Iniziato | SVB Leerink | Outperform |
| 2019-03-15 | Reiterato | H.C. Wainwright | Buy |
| 2016-10-03 | Ripresa | Brean Capital | Buy |
| 2015-12-15 | Iniziato | Cantor Fitzgerald | Buy |
| 2015-12-14 | Iniziato | Ladenburg Thalmann | Buy |
Mostra tutto
Axsome Therapeutics Inc Borsa (AXSM) Ultime notizie
Axsome at Wells Fargo Conference: Growth and Strategic Expansions - Investing.com
214,139 Shares in Axsome Therapeutics, Inc. $AXSM Acquired by Driehaus Capital Management LLC - MarketBeat
Axsome initiated with Overweight at Wells Fargo on Alzheimer's drug potential - MSN
Wells Fargo Initiates Axsome Therapeutics with Overweight Rating, $163 Price Target - AInvest
Axsome Therapeutics Insider Sold Shares Worth $7,303,400, According to a Recent SEC Filing - 富途牛牛
Why Is Axsome (AXSM) Up 19.2% Since Last Earnings Report? - Yahoo Finance
Will Axsome Therapeutics Inc. stock recover after recent dropEarnings Trend Report & Technical Buy Zone Confirmation - Newser
What to do if you’re stuck in Axsome Therapeutics Inc.Watch List & Safe Capital Investment Plans - Newser
Best data tools to analyze Axsome Therapeutics Inc. stock2025 Institutional Moves & Free Weekly Chart Analysis and Trade Guides - Newser
What’s the recovery path for long term holders of Axsome Therapeutics Inc.2025 EndofYear Setup & Free Expert Verified Stock Movement Alerts - Newser
Axsome Therapeutics stock rated Overweight by Wells Fargo - Investing.com Australia
PDT Partners LLC Purchases 47,004 Shares of Axsome Therapeutics, Inc. $AXSM - MarketBeat
Forecasting Axsome Therapeutics Inc. price range with options dataQuarterly Profit Review & AI Based Buy and Sell Signals - Newser
Ranking Axsome Therapeutics Inc. among high performing stocks via toolsRate Cut & Weekly Chart Analysis and Trade Guides - Newser
Axsome Therapeutics, Inc. $AXSM Shares Sold by Russell Investments Group Ltd. - MarketBeat
Published on: 2025-09-03 05:51:54 - Newser
Point72 Europe London LLP Cuts Holdings in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Tema Etfs LLC Takes Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Chart based analysis of Axsome Therapeutics Inc. trendsCPI Data & Weekly Top Performers Watchlists - Newser
What’s next for Axsome Therapeutics Inc. stock price2025 Market WrapUp & Expert-Curated Trade Recommendations - Newser
Why Axsome Therapeutics Inc. is moving todayCEO Change & Smart Money Movement Alerts - Newser
Applying big data sentiment scoring on Axsome Therapeutics Inc.2025 Market Trends & Detailed Earnings Play Strategies - Newser
What earnings revisions data tells us about Axsome Therapeutics Inc.Trade Signal Summary & Daily Oversold Stock Bounce Ideas - Newser
Published on: 2025-09-03 02:19:56 - Newser
Northern Trust Corp Buys 8,469 Shares of Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome Therapeutics, Inc. $AXSM is Tri Locum Partners LP's 7th Largest Position - MarketBeat
What does recent volatility data suggest for Axsome Therapeutics Inc.Market Growth Summary & Scalable Portfolio Growth Methods - Newser
Axsome therapeutics director Jeffs sells $1.66 million in stock - Investing.com
Axsome Therapeutics Director JEFFS ROGER Sells 13,464 Shares at $123.68. - AInvest
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Given Average Recommendation of "Buy" by Brokerages - MarketBeat
Published on: 2025-09-03 01:34:58 - khodrobank.com
Axsome Therapeutics shares rise 1.58% intraday after insider sold shares. - AInvest
Order flow analysis tools used on Axsome Therapeutics Inc.2025 Earnings Surprises & Fast Momentum Entry Tips - Newser
Applying chart zones and confluence areas to Axsome Therapeutics Inc.July 2025 EndofMonth & Pattern Based Trade Signal System - Newser
Landscape Capital Management L.L.C. Makes New $632,000 Investment in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome Shares Up 20% in a Month: How Should You Play the Stock? - MSN
Momentum divergence signals in Axsome Therapeutics Inc. chartDip Buying & Reliable Entry Point Alerts - Newser
Raymond James Financial Inc. Cuts Stock Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome Therapeutics: Fortifying Market Dominance Through Strategic Patent Portfolios and Franchise Resilience - AInvest
H.C. Wainwright Reaffirms Buy on Axsome (AXSM) Following Generic Challenge to Portfolio - Yahoo Finance
Can Axsome Therapeutics Inc. recover in the next quarterJuly 2025 Trade Ideas & Long-Term Growth Portfolio Plans - Newser
US Stocks Recap: Is Axsome Therapeutics Inc. subject to activist investor interestJuly 2025 Weekly Recap & Technical Pattern Based Signals - خودرو بانک
Can Axsome Therapeutics Inc. continue delivering strong returnsJuly 2025 Sentiment & Fast Entry High Yield Tips - خودرو بانک
FORA Capital LLC Buys Shares of 7,633 Axsome Therapeutics, Inc. $AXSM - MarketBeat
Can technical indicators confirm Axsome Therapeutics Inc.’s reversalChart Signals & Verified Technical Signals - Newser
Published on: 2025-09-01 11:39:02 - Newser
Is now a turning point for Axsome Therapeutics Inc.2025 Performance Recap & AI Powered Buy and Sell Recommendations - Newser
Axsome Therapeutics Inc.’s volatility index tracking explainedJuly 2025 Summary & Free Technical Confirmation Trade Alerts - Newser
Quantitative Investment Management LLC Takes Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Affinity Asset Advisors LLC Increases Stock Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q2 2025 Earnings Call Transcript - MSN
Axsome Therapeutics Inc Azioni (AXSM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):